Jorg Riesmeier, PhD

Entrepreneur, Investor, CEO, Chairman, Board Member, Advisor

Berlin Metropolitan Area

About

Biotech entrepreneur and investor with 25+ years of turning science into scalable ventures. Built and sold PlantTec to Bayer, raised €100M+ and managed €200M in VC funds, led six portfolio companies, and drove exits like Pasteuria (Syngenta) and Glycotope (€140M). Former CEO of Direvo. Now CEO of Nuvio Planet GmbH, driving the transformation toward a more transparent, data-driven, and sustainable agrifood system.

Experience

  • Co-Founder & Co-CEO at Nuvio Planet
    Jul 2025 - Present · 1 yr 1 mo

    Nuvio Planet is the environmental intelligence platform helping food industry leaders turn sustainability into a growth driver. Trusted by global players, we deliver product-specific insights that go far beyond carbon-capturing impacts on land, water, soil, and more.

  • Principal at NextStepsBiotech
    May 2017 - Present · 9 yrs 3 mos

    Operating as advisor, interim CxO, and board chair across deep-tech ventures. As Chairman of the Board helped reposition Glycotope in oncology and supported its €140M exit; also active in due diligence support with Yara Ventures, Entrepreneur-in-Residence at Chemovator GmbH and interim's CEO at MetaSysX GmbH.

  • Member of the Investment Committee @Chemovator at BASF
    Nov 2018 - Jun 2025 · 6 yrs 8 mos

    Shaping investment decissions at the BASF company builder Chemovator GmbH. Supporting entrepreneurs on their journey building scalable succesful ventures. 10+ venture board seats.

  • CEO & Managing Director at Direvo Industrial Biotechnology GmbH
    Jan 2010 - Apr 2017 · 7 yrs 4 mos

    Pivoted the company from CRO to product-focused biotech, launching enzyme solutions for the U.S. ethanol market. Streamlined operations and secured strategic partnerships with BASF, Evonik, and Wacker.

  • General Partner at LSP (Life Sciences Partners)
    Jun 2006 - Jan 2010 · 3 yrs 8 mos

    Raised €100M as General Partner and built LSP’s U.S. presence from the ground up. Led investments in six companies and held full board seats, supporting successful exits like Pasteuria (to Syngenta).